Brawn Biotech (BOM:530207) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530207 Brawn Biotech Ltd BOM:530207
55 GF Score
Price ₹20.21
GF Value ₹20.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Brawn Biotech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


BOM:530207 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Brawn Biotech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brawn Biotech Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brawn Biotech's Short Interest distribution charts can be found below:

* The bar in red indicates where Brawn Biotech's Short Interest falls into.


BOM:530207
55GF Score
Brawn Biotech Ltd BOM:530207
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Brawn Biotech (BOM:530207) Overvalued in 2026?

Based on GuruFocus' analysis, Brawn Biotech stock appears to be undervalued. The current stock price of ₹20.21 is trading 1.4% below its estimated GF Value™ of ₹20.49. GuruFocus considers Brawn Biotech to be Fairly Valued.

Key valuation signals for BOM:530207:

  • Short Interest:
  • GF Value™: ₹20.49 vs. price of ₹20.21 (1.4% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the BOM:530207 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Brawn Biotech Business Description

Address Lajpat Nagar-1, C-64, First Floor, New Delhi, IND, 110024
Brawn Biotech Ltd is a healthcare company. It is engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals.
55GF Score

Get the complete analysis for BOM:530207

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹20.21
Price
₹20.49
GF Value